Clinical Trial Update: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study of MDX-1106 in patients with selected refractory or relapsed malignancies has completed, with results posted in 2015. The trial included Non-Sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Prostate Cancer
• Renal Cell Carcinoma

Drugs mentioned

• MDX-1106

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Carcinoma, Non-Small-Cell Lung, Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-02-20